| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men RM Grant, JR Lama, PL Anderson, V McMahan, AY Liu, L Vargas, ... New England Journal of Medicine 363 (27), 2587-2599, 2010 | 6012 | 2010 |
| Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study RM Grant, PL Anderson, V McMahan, A Liu, KR Amico, M Mehrotra, ... The Lancet infectious diseases 14 (9), 820-829, 2014 | 1337 | 2014 |
| Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men PL Anderson, DV Glidden, A Liu, S Buchbinder, JR Lama, JV Guanira, ... Science translational medicine 4 (151), 151ra125-151ra125, 2012 | 1106 | 2012 |
| Cabotegravir for HIV prevention in cisgender men and transgender women RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ... New England Journal of Medicine 385 (7), 595-608, 2021 | 565 | 2021 |
| Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 … R Palacios, EG Patiño, R de Oliveira Piorelli, MTRP Conde, AP Batista, ... Trials 21, 1-3, 2020 | 348 | 2020 |
| Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans DI Watkins, DR Burton, EG Kallas, JP Moore, WC Koff Nature medicine 14 (6), 617-621, 2008 | 338 | 2008 |
| Circulating follicular helper–like T cells in systemic lupus erythematosus: association with disease activity JY Choi, JH Ho, SG Pasoto, V Bunin, ST Kim, S Carrasco, EF Borba, ... Arthritis & rheumatology 67 (4), 988-999, 2015 | 320 | 2015 |
| International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for … TC Mast, L Kierstead, SB Gupta, AA Nikas, EG Kallas, V Novitsky, ... Vaccine 28 (4), 950-957, 2010 | 316 | 2010 |
| HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial MB Deutsch, DV Glidden, J Sevelius, J Keatley, V McMahan, J Guanira, ... The lancet HIV 2 (12), e512-e519, 2015 | 309 | 2015 |
| No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis JL Marcus, DV Glidden, KH Mayer, AY Liu, SP Buchbinder, KR Amico, ... PloS one 8 (12), e81997, 2013 | 305 | 2013 |
| Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial MM Solomon, KH Mayer, DV Glidden, AY Liu, VM McMahan, JV Guanira, ... Clinical Infectious Diseases 59 (7), 1020-1026, 2014 | 207 | 2014 |
| Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock PS Martins, EG Kallas, MC Neto, MA Dalboni, S Blecher, R Salomão Shock 20 (3), 208-212, 2003 | 204 | 2003 |
| Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial AC Medeiros-Ribeiro, NE Aikawa, CGS Saad, EFN Yuki, T Pedrosa, ... Nature medicine 27 (10), 1744-1751, 2021 | 203 | 2021 |
| Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study R Palacios, AP Batista, CSN Albuquerque, EG Patiño, JP Santos, ... | 201 | 2021 |
| Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study B Grinsztejn, B Hoagland, RI Moreira, EG Kallas, JV Madruga, S Goulart, ... The lancet HIV 5 (3), e136-e145, 2018 | 194 | 2018 |
| Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans A Grifoni, J Pham, J Sidney, PH O'Rourke, S Paul, B Peters, SR Martini, ... Journal of virology 91 (24), 10.1128/jvi. 01469-17, 2017 | 189 | 2017 |
| Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis MM Solomon, JR Lama, DV Glidden, K Mulligan, V McMahan, AY Liu, ... Aids 28 (6), 851-859, 2014 | 184 | 2014 |
| Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal FA Legrand, DF Nixon, CP Loo, E Ono, JM Chapman, M Miyamoto, ... PloS one 1 (1), e102, 2006 | 180 | 2006 |
| Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository R Kassanjee, CD Pilcher, SM Keating, SN Facente, E McKinney, MA Price, ... Aids 28 (16), 2439-2449, 2014 | 168 | 2014 |
| QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans TG Evans, MJ McElrath, T Matthews, D Montefiori, K Weinhold, M Wolff, ... Vaccine 19 (15-16), 2080-2091, 2001 | 168 | 2001 |
